# Smell, Voice and Nasal Swabs as Markers for Neuro-degenerative Disorders

> **NCT03299062** · NA · COMPLETED · sponsor: **University of Arkansas** · enrollment: 9 (actual)

## Conditions studied

- Alzheimer Disease
- Neurodegenerative Diseases

## Interventions

- **DIAGNOSTIC_TEST:** Cytology and Immunohistochemistry

## Key facts

- **NCT ID:** NCT03299062
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-14
- **Primary completion:** 2021-12-21
- **Final completion:** 2021-12-21
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2022-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03299062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03299062, "Smell, Voice and Nasal Swabs as Markers for Neuro-degenerative Disorders". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT03299062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*